| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anogenital lichen sclerosus et atrophicus lesions in a case series of cancer patients on immunotherapy
|
Conteduca, V.
|
|
|
71 |
6 |
p. 1545-1548
|
artikel
|
| 2 |
Camrelizumab in different PD-L1 expression cohorts of pre-treated advanced or metastatic non-small cell lung cancer: a phase II study
|
Yang, Jin-Ji
|
|
|
71 |
6 |
p. 1393-1402
|
artikel
|
| 3 |
CD4 + T cells are found within endemic Burkitt lymphoma and modulate Burkitt lymphoma precursor cell viability and expression of pathogenically relevant Epstein–Barr virus genes
|
Sidorov, Semjon
|
|
|
71 |
6 |
p. 1371-1392
|
artikel
|
| 4 |
Clinical determinants of long-term survival in metastatic uveal melanoma
|
Koch, Elias A. T.
|
|
|
71 |
6 |
p. 1467-1477
|
artikel
|
| 5 |
Comprehensive characterization of tumor immune landscape following oncolytic virotherapy by single-cell RNA sequencing
|
Ravirala, Divya
|
|
|
71 |
6 |
p. 1479-1495
|
artikel
|
| 6 |
Cyclic sulfur compounds targeting macrophage polarization into M2/protumor phenotype and their anti-tumor effects
|
Pan, Cheng
|
|
|
71 |
6 |
p. 1331-1343
|
artikel
|
| 7 |
Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit
|
Nickles, Emily
|
|
|
71 |
6 |
p. 1531-1543
|
artikel
|
| 8 |
Efficacy and safety of Wilms’ tumor 1 helper peptide OCV-501 in elderly patients with acute myeloid leukemia: a multicenter, randomized, double-blind, placebo-controlled phase 2 trial
|
Kiguchi, Toru
|
|
|
71 |
6 |
p. 1419-1430
|
artikel
|
| 9 |
First-line treatment options for advanced non-small cell lung cancer patients with PD-L1 ≥ 50%: a systematic review and network meta-analysis
|
He, Mingfeng
|
|
|
71 |
6 |
p. 1345-1355
|
artikel
|
| 10 |
Identification and quantification of immune infiltration landscape on therapy and prognosis in left- and right-sided colon cancer
|
Guo, Jun-Nan
|
|
|
71 |
6 |
p. 1313-1330
|
artikel
|
| 11 |
Immunogenic senescence sensitizes lung cancer to LUNX-targeting therapy
|
Jiao, Defeng
|
|
|
71 |
6 |
p. 1403-1417
|
artikel
|
| 12 |
Infiltration and Polarization of Tumor-associated Macrophages Predict Prognosis and Therapeutic Benefit in Muscle-Invasive Bladder Cancer
|
Sun, Mengmeng
|
|
|
71 |
6 |
p. 1497-1506
|
artikel
|
| 13 |
Intravesical Pseudomonas aeruginosa mannose-sensitive Hemagglutinin vaccine triggers a tumor-preventing immune environment in an orthotopic mouse bladder cancer model
|
Wang, Bo
|
|
|
71 |
6 |
p. 1507-1517
|
artikel
|
| 14 |
Molecular imaging of cellular immunotherapies in experimental and therapeutic settings
|
Shalaby, Nourhan
|
|
|
71 |
6 |
p. 1281-1294
|
artikel
|
| 15 |
PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer
|
Takahashi, Miho
|
|
|
71 |
6 |
p. 1357-1369
|
artikel
|
| 16 |
PD-1 expression in hepatocellular carcinoma predicts liver-directed therapy response and bridge-to-transplant survival
|
Núñez, Kelley G.
|
|
|
71 |
6 |
p. 1453-1465
|
artikel
|
| 17 |
Prediction of prognosis and immunotherapy response with a robust immune-related lncRNA pair signature in lung adenocarcinoma
|
Cao, Kui
|
|
|
71 |
6 |
p. 1295-1311
|
artikel
|
| 18 |
Prognostic value of preoperative soluble interleukin 2 receptor α as a novel immune biomarker in epithelial ovarian cancer
|
Li, Hui
|
|
|
71 |
6 |
p. 1519-1530
|
artikel
|
| 19 |
Real-world outcomes of regorafenib combined with immune checkpoint inhibitors in patients with advanced or metastatic microsatellite stable colorectal cancer: A multicenter study
|
Yang, Kaili
|
|
|
71 |
6 |
p. 1443-1451
|
artikel
|
| 20 |
Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer
|
Qin, Meng
|
|
|
71 |
6 |
p. 1431-1442
|
artikel
|
Tijdschrift beschrijving